Search Results - "Zhang, Jiasi Vicky"
-
1
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
Published in Frontiers in oncology (10-09-2021)“…Tumor heterogeneity is a key reason for therapeutic failure and tumor recurrence in glioblastoma (GBM). Our chimeric antigen receptor (CAR) T cell (2173 CAR T…”
Get full text
Journal Article -
2
Neurofilament Light Chain Is Related to Longitudinal Decline in Frontotemporal Lobar Degeneration
Published in Neurology. Clinical practice (01-12-2021)Get full text
Journal Article -
3
Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis
Published in Cellular and molecular life sciences : CMLS (01-10-2023)“…Background Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. There is no cure currently. The discovery that mutations in the gene…”
Get full text
Journal Article -
4
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors
Published in Molecular therapy (06-07-2022)“…Bispecific T cell engagers (BiTEs) are bispecific antibodies that redirect T cells to target antigen-expressing tumors. We hypothesized that BiTE-secreting…”
Get full text
Journal Article -
5
Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides
Published in Cell reports (Cambridge) (07-06-2022)“…We analyze transposable elements (TEs) in glioblastoma (GBM) patients using a proteogenomic pipeline that combines single-cell transcriptomics, bulk RNA…”
Get full text
Journal Article -
6
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma
Published in Molecular therapy (02-10-2024)“…Chimeric antigen receptor (CAR) T cells have shown significant efficacy in hematological diseases. However, CAR T therapy has demonstrated limited efficacy in…”
Get more information
Journal Article -
7
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
Published in Cancer immunology research (01-07-2022)“…Glioblastoma (GBM) is an immunologically "cold" tumor characterized by poor responsiveness to immunotherapy. Standard of care for GBM is surgical resection…”
Get more information
Journal Article -
8
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration
Published in Neurology. Clinical practice (01-04-2021)“…Accurate diagnosis and prognosis of frontotemporal lobar degeneration (FTLD) during life is an urgent concern in the context of emerging disease-modifying…”
Get full text
Journal Article